An Open Letter to the American Diabetes Association: Petition initiated by David Nathan, distinguished diabetes physician at Mass General and Harvard Medical School.
#ADASciSessions
c.org/Q8JcJBwG8H via Change.org
If the goal was to stir controversy, leadership executed yesterday's opening of #ADASciSessions brilliantly. But we rather doubt this is what ADA had in mind. Sending police after distinguished scientists is not good.
conscienhealth.org/2026/06/06/a...
An Open Letter to the American Diabetes Association: Shame on You
As the #ADASciSessions came to a close in New Orleans, it became clear that obesity medicines are entering a new phase of growth.
conscienhealth.org/2026/06/09/a...
Controversy swirling around ADA leadership at the #ADASciSessions deepened today as the President-Elect and Scientific Sessions Planning Committee Chair resigned.
conscienhealth.org/2026/06/08/a...
Survodutide, a dual GLP-1/glucagon agonist grabbed the spotlight at #ADASciSessions yesterday with evidence that it has metabolic benefits in obesity beyond weight loss.
conscienhealth.org/2026/06/08/a...
The big winner at #ADASciSessions seems to be @elilillyandcompany.bsky.social with #retatrutide. Yes, it delivers remarkable weight loss outcomes. But unlocking the meaning of these results in clinical care will take some time.
conscienhealth.org/2026/06/10/a...
Will an apology for "events that occurred" without owning the mistake of calling out police against your most respected scientists make this "moral stain" on the @amdiabetesassn.bsky.social go away? We have our doubts.
conscienhealth.org/2026/06/11/a...
At the #ADASciSessions, it is clear that injecting politics into science has proven to be a terrible distraction.
conscienhealth.org/2026/06/07/a...
All generalizations are dangerous. Including generalizations about ultra-processed foods. A new analysis in @science.org Magazine offers caution about the "war" on ultra-processed foods we are marching toward.
conscienhealth.org/2026/06/12/d...
In a wave of new data on amylin agonists, it's becoming clear that the interest in these drugs is all about tolerability. Zealand, Roche, @elilillyandcompany.bsky.social, @novonordisk.bsky.social & others are making bets on this class of drugs.
conscienhealth.org/2026/06/07/a...
